Unlike GLP-1, the elevated levels of PYY post-surgery may contribute to longer-term improvements in obesity and glucose tolerance, highlighting its substantial and lasting role in weight reduction compared to GLP-1 [57]. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.